Guanfacine Tablet, Extended Release
Product Images NDC 29300-463

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Guanfacine (NDC 29300-463). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Unichem Pharmaceuticals (usa), Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 01 (Bc9cc5d2 E098 41da Ae90 0944715d6b92 01)

Chemical structure of guanfacine hydrochloride, showing a chlorinated bicyclic ring attached to an amide group and a guanidine moiety.*

FDA Label Image

Image (Bc9cc5d2 E098 41da Ae90 0944715d6b92 02)

A line graph comparing plasma concentration of Guanfacine over 24 hours between Guanfacine Extended-Release Tablets 1 mg once daily and Tenex 1 mg once daily. The y-axis shows Guanfacine plasma concentration in ng/mL, and the x-axis shows time in hours. Guanfacine ER shows a slower rise and more sustained concentration compared to Tenex's sharper peak and decline.*

FDA Label Image

Figure 2 (Bc9cc5d2 E098 41da Ae90 0944715d6b92 03)

A clinical pharmacokinetic chart displaying fold change and 90% confidence intervals for peak concentration (Cmax) and area under the curve (AUC) in response to various CYP3A4/5 inhibitors and inducers, including ketoconazole, fluconazole, rifampin, efavirenz, oral methylphenidate, and lisdexamfetamine dimesylate. The chart compares changes relative to reference values.*

FDA Label Image

Figure 3 (Bc9cc5d2 E098 41da Ae90 0944715d6b92 04)

A chart showing pharmacokinetic fold changes with 90% confidence intervals for oral methylphenidate and lisdexamfetamine dimesylate. The graph plots Cmax and AUC values relative to a reference, with a horizontal axis indicating change from 0.0 to 2.0 fold.*

FDA Label Image

Figure-04 (Bc9cc5d2 E098 41da Ae90 0944715d6b92 05)

A Kaplan-Meier survival curve showing time to treatment failure over days for two groups: Placebo and SFID503. The vertical axis indicates the treatment failure rate percentage, and the horizontal axis represents time in days from 0 to 203. The graph compares treatment outcomes between the two groups.*

FDA Label Image

Image (Bc9cc5d2 E098 41da Ae90 0944715d6b92 06)

FDA Label Image

Guanfacine Extended-release Tablets (1mg)

Label for Guanfacine Extended-Release Tablets, USP 1 mg, oral dosage form. The label indicates 100 tablets per package and is manufactured by Unichem Laboratories Ltd., India, for Unichem Pharmaceuticals (USA), Inc. Storage instructions specify controlled room temperature between 20° to 25°C. The label includes a National Drug Code (NDC) 29300-460-01 and notes the tablets should not be crushed, chewed, or broken before swallowing.*

FDA Label Image

Guanfacine Extended-release Tablets (2mg)

Label for Guanfacine Extended-Release Tablets, USP 2 mg by Unichem Pharmaceuticals (USA), Inc. The label states the tablet strength as 2 mg and includes storage instructions, a caution that tablets should not be crushed, chewed, or broken, and packaging details for 100 tablets. It also lists manufacturing information for Unichem Laboratories Ltd. in India and Unichem Pharmaceuticals (USA), Inc. in New Jersey.*

FDA Label Image

Guanfacine Extended-release Tablets (3mg)

Label for Guanfacine Extended-Release Tablets, USP 3 mg, oral dosage form. The label indicates the product is manufactured by Unichem Laboratories Ltd and labeled by Unichem Pharmaceuticals (USA), Inc. It includes dosage strength, storage instructions, and a barcode. The package contains 100 tablets and advises the tablets should not be crushed, chewed, or broken before swallowing.*

FDA Label Image

Guanfacine Extended-release Tablets (4mg)

Label for Guanfacine Extended-Release Tablets USP, 4 mg strength. The label includes storage instructions, dosage advice to see package insert, and a warning to keep out of reach of children. The labeler is Unichem Pharmaceuticals (USA), Inc., with manufacturing by Unichem Laboratories Ltd. The package contains 100 tablets.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.